Jiangxi Bestcare Pharmaceuticals invested 260 million yuan to expand the project of hormone raw material intermediates such as cortisone acetate and canrenone intermediates
More Market Insights
-
Entreprise Dynamic
Jiangxi Bestcare Pharmaceuticals invested 260 million yuan to expand the project of hormone raw material intermediates such as cortisone acetate and canrenone intermediates -
Special Report
Hubei University of Technology and Hubei Joint Pharmaceutical Co., Ltd. carry out the 'Steroid Hormone Intermediate Technology Achievement Transformation and Industrialization' project cooperation
Breaking News
-
Benzene Monthly Report (202609)
Oct 9 -
[Toluene]: October 1, 2026 International Toluene Market Price News
Oct 8 -
[VCM]: Asian Market VCM Price on October 8
Oct 8 -
[Ethylene]: Asian ethylene market overview (2026-10-09)
Oct 9 -
Aniline Monthly Report (202609)
Oct 9 -
1,3-Butadiene Weekly Report (October 05, 2026 - October 11, 2026)
Oct 12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)